Ever wonder why SARS-CoV-2 was so successful in infecting different people, even those who were otherwise healthy and had a robust immune system? Part of the reason could be the ability of the virus to dampen the anti-viral innate immune response by impairing the mechanism of interferon production in host cells. In collaboration with Tommy Alain's team at University of Ottawa, we wrote a mini-review that distills the latest findings on all the ingenious ways through which SARS-CoV-2 block interferon production in host cells. Find the paper here and enjoy reading!
top of page
Search
Recent Posts
See AllIt is sometimes difficult to tease apart the molecular functions and biological roles of paralog proteins. In this preprint we do just that for GIGYF1, a protein that has for years been overshadowed b
Check out Parisa's new paper in Journal of Cell Science. We had shown in the past that the cap-binding protein 4EHP is a critical component of the mechanism that mediates the microRNA-induced translat
Congratulations to our collaborators at Sossin lab (Montreal Neurological Institute) and Gkogkas lab (Foundation for Research and Technology-Hellas) for publication of their very enticing new paper on
bottom of page